Results 141 to 150 of about 65,110 (152)

GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS

2020
COATES DAVID ANDREW, FIELDS TODD, HO JOSEPH DANIEL, QU FUCHENG   +3 more
openaire   +3 more sources

Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis

Diabetes, 2015
Daniel J. Drucker, Jonathan Campbell, Thomas Secher   +2 more
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis

Gastroenterology
Sena Cakir Colak, Yu-Cheng Chang
exaly  

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis

Clinical Gastroenterology and Hepatology
Antonio Facciorusso
exaly  

Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes

American Journal of Obstetrics and Gynecology
Marisa R Imbroane
exaly  

Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?

Circulation
Jennifer Linge, Andreas Birkenfeld, Ian J Neeland   +2 more
exaly  

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation

Cell Metabolism
Daniel J. Drucker, Brent McLean, Nikolaj Rittig   +2 more
exaly  

Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis

Journal of Hepatology
Naim Alkhouri, Daniel Mazo, Jörn M Schattenberg   +2 more
exaly  

Glucagon-Like Peptide 1 Receptor Agonist

openaire   +1 more source